Antibodies

Roche and Earendil Forge $1.5 Billion Bispecific Antibody Discovery Deal

Yuvraj — Sat, 26 Sep 2026 04:50:59 +0000

Roche-owned Genentech has entered into a major collaboration with Earendil Labs to discover and develop bispecific antibodies targeting oncology, in a deal valued at up to $1.5 billion. Deal Structure and Financial Terms Under the terms of the agreement, Earendil will receive $55 million upfront, along with up to $1.445 billion in development, regulatory, and […]

The post Roche and Earendil Forge $1.5 Billion Bispecific Antibody Discovery Deal first appeared on World Pharma Today.

Injectable Drug Formulation Trends in Biopharma

Yuvraj — Fri, 06 Feb 2026 13:10:50 +0000

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.

The post Injectable Drug Formulation Trends in Biopharma first appeared on World Pharma Today.

Indian Pharma Grows 8% CAGR, Surpassing Global Average

Yuvraj — Sat, 08 Mar 2025 08:01:54 +0000

The Indian pharma sector has seen 8% CAGR growth and at the same time has witnessed a 9% rise when it comes to export rates in 2024, as per one of the reports. McKinsey & Company’s report has shown that the pharma sector in India happens to be witnessing very fast growth as far as […]

The post Indian Pharma Grows 8% CAGR, Surpassing Global Average first appeared on World Pharma Today.